technetium tc 99m hydroxymethylene diphosphonate has been researched along with Sclerosis in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cho, I; Fukuchi, K; Hayashida, K; Imakita, S; Ishida, Y; Kume, N; Kumita, S; Shimotsu, Y; Takamiya, M; Toba, M | 1 |
1 other study(ies) available for technetium tc 99m hydroxymethylene diphosphonate and Sclerosis
Article | Year |
---|---|
Increased bone mineral turnover without increased glucose utilization in sclerotic and hyperplastic change in fibrous dysplasia.
Topics: Bone Density; Facial Bones; Female; Fibrous Dysplasia, Polyostotic; Fluorodeoxyglucose F18; Glucose; Humans; Hyperplasia; Middle Aged; Radiopharmaceuticals; Sclerosis; Skull; Technetium Tc 99m Medronate; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed | 1998 |